Repositorio Dspace

Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina

Mostrar el registro sencillo del ítem

dc.contributor.author Di-Pierdomenico, Johnny
dc.contributor.author Gallego-Ortega, Alejandro
dc.contributor.author Norte-Muñoz, María
dc.contributor.author Vidal-Villegas, Beatriz
dc.contributor.author Bravo, Isaac
dc.contributor.author Boluda-Ruiz, María
dc.contributor.author Bernal-Garro, José-Manuel
dc.contributor.author Fernández-Bueno, Iván
dc.contributor.author Pastor-Jimeno, José-Carlos
dc.contributor.author Villegas-Pérez, María-Paz
dc.contributor.author Avilés-Trigueros, Marcelino
dc.contributor.author de-los-Ríos, Cristóbal
dc.contributor.author Vidal-Sanz, Manuel
dc.date.accessioned 2025-11-21T08:46:56Z
dc.date.available 2025-11-21T08:46:56Z
dc.date.issued 2024-02
dc.identifier.citation Di Pierdomenico J, Gallego-Ortega A, Norte-Muñoz M, Vidal-Villegas B, Bravo I, Boluda-Ruiz M, et al. Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina. Front Neuroanat. 13 de febrero de 2024;18:1335176.
dc.identifier.issn 1662-5129
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21999
dc.description.abstract PURPOSE: The aim of this study was to investigate, the neuroprotective effects of a new Gramine derivative named: ITH12657, in a model of retinal excitotoxicity induced by intravitreal injection of NMDA. METHODS: Adult Sprague Dawley rats received an intravitreal injection of 100 mM NMDA in their left eye and were treated daily with subcutaneous injections of ITH12657 or vehicle. The best dose-response, therapeutic window study, and optimal treatment duration of ITH12657 were studied. Based on the best survival of Brn3a + RGCs obtained from the above-mentioned studies, the protective effects of ITH12657 were studied in vivo (retinal thickness and full-field Electroretinography), and ex vivo by quantifying the surviving population of Brn3a + RGCs, ?RGCs and their subtypes ?-ONsRGCs, ?-ONtRGCs, and ?-OFFRGCs. RESULTS: Administration of 10 mg/kg ITH12657, starting 12 h before NMDA injection and dispensed for 3 days, resulted in the best significant protection of Brn3a + RGCs against NMDA-induced excitotoxicity. In vivo, ITH12657-treated rats showed significant preservation of retinal thickness and functional protection against NMDA-induced retinal excitotoxicity. Ex vivo results showed that ITH12657 afforded a significant protection against NMDA-induced excitotoxicity for the populations of Brn3a + RGC, ?RGC, and ?ONs-RGC, but not for the population of ?OFF-RGC, while the population of ?-ONtRGC was fully resistant to NMDA-induced excitotoxicity. CONCLUSION: Subcutaneous administration of ITH12657 at 10 mg/kg, initiated 12 h before NMDA-induced retinal injury and continued for 3 days, resulted in the best protection of Brn3a + RGCs, ?RGC, and ?ONs-RGC against excitotoxicity-induced RGC death. The population of ?OFF-RGCs was extremely sensitive while ?-ONtRGCs were fully resistant to NMDA-induced excitotoxicity.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Evaluation of the neuroprotective efficacy of the gramine derivative ITH12657 against NMDA-induced excitotoxicity in the rat retina
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 38415017
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fnana.2024.1335176/full
dc.identifier.doi 10.3389/fnana.2024.1335176
dc.journal.title Frontiers in Neuroanatomy


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta